| GENOVIS AB SE-,40 |
| Schweden |
| Gesundheit |
| SE0002485979 / A0Q4ER |
| 5GV (Frankfurt) |
| FRA:5GV, ETR:5GV, 5GV:GR |
| - |
| https://www.genovis.com/ |
|
Genovis AB is a biotechnology company specializing in the development of enzyme-based solutions for the healthcare and life sciences sector. The primary focus of Genovis is to provide enzymatic tools for advanced applications in protein analysis and ..
>Volltext.. |
| 112.14 Mio. EUR |
| 103.84 Mio. EUR |
| 12.09 Mio. EUR |
| 3.73 Mio. EUR |
| 2.2 Mio. EUR |
| 0.03 EUR |
| 6.85 Mio. EUR |
| 15.3 Mio. EUR |
| 3 Mio. EUR |
| 5.81 |
| 4.82% |
| -24.35% |
| - |
| - |
| - |
| - |
| GENOVIS |
| 05.04.26 |
|